Cronos Group/$CRON
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Cronos Group
Cronos Group Inc headquartered in Toronto, Canada, cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S., the company has an option to acquire 5.9% of U.S. multistate operator PharmaCann on a fully diluted basis upon easing of federal prohibition.
Ticker
$CRON
Sector
Primary listing
Employees
459
Headquarters
Stayner, Canada
Website
Cronos Group Metrics
BasicAdvanced
$1.2B
34.73
$0.09
1.05
-
Price and volume
Market cap
$1.2B
Beta
1.05
52-week high
$3.29
52-week low
$1.60
Average daily volume
2.3M
Financial strength
Current ratio
22.455
Quick ratio
20.994
Long term debt to equity
0.103
Total debt to equity
0.154
Dividend payout ratio (TTM)
10.69%
Profitability
EBITDA (TTM)
-13.624
Gross margin (TTM)
38.75%
Net profit margin (TTM)
27.27%
Operating margin (TTM)
-19.82%
Effective tax rate (TTM)
-0.71%
Revenue per employee (TTM)
$290,000
Management effectiveness
Return on assets (TTM)
-1.39%
Return on equity (TTM)
3.67%
Valuation
Price to earnings (TTM)
34.733
Price to revenue (TTM)
9.473
Price to book
1.59
Price to tangible book (TTM)
1.71
Price to free cash flow (TTM)
-218.481
Free cash flow yield (TTM)
-0.46%
Free cash flow per share (TTM)
-0.015
Growth
Revenue change (TTM)
19.00%
Earnings per share change (TTM)
-175.76%
3-year revenue growth (CAGR)
13.51%
10-year revenue growth (CAGR)
77.01%
3-year earnings per share growth (CAGR)
-45.96%
10-year earnings per share growth (CAGR)
-0.10%
What the Analysts think about Cronos Group
Analyst ratings (Buy, Hold, Sell) for Cronos Group stock.
Cronos Group Financial Performance
Revenues and expenses
Cronos Group Earnings Performance
Company profitability
Cronos Group News
AllArticlesVideos
Cannabis stocks spike on reports Trump plans to ease federal pot restrictions
New York Post·2 days ago
Trump Expected to Label Pot a Less Dangerous Drug
Bloomberg Markets and Finance·2 days ago
Trump expected to sign executive order to reclassify marijuana as soon as Monday, source tells CNBC
CNBC Television·2 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cronos Group stock?
Cronos Group (CRON) has a market cap of $1.2B as of December 15, 2025.
What is the P/E ratio for Cronos Group stock?
The price to earnings (P/E) ratio for Cronos Group (CRON) stock is 34.73 as of December 15, 2025.
Does Cronos Group stock pay dividends?
No, Cronos Group (CRON) stock does not pay dividends to its shareholders as of December 15, 2025.
When is the next Cronos Group dividend payment date?
Cronos Group (CRON) stock does not pay dividends to its shareholders.
What is the beta indicator for Cronos Group?
Cronos Group (CRON) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.